Nowadays oocyte donation is a well established method of assisted reproduct
ion and offers the unique opportunity to treat patients with various clinic
al indications, with or without ovarian function. in a novel way. In women
with ovarian failure, artificial menstrual cycles are required before proce
eding to oocyte donation. Oestrogen may be delivered in the form of oral ta
blets, transdermal patches in order to bypass the gastrointestinal tract th
us avoiding first pass metabolism and by vaginal application. Our regimen i
s oestradiol valerate given in various concentrations, in order to mimic th
e regular cyclic fluctuations throughout the cycle. Progesterone may be adm
inistered in the form of oral tablets, intravaginal suppositories or rings
and i.m. injections. Our results, as of most other groups, strongly support
the vaginal route of progesterone administration. In women with retained o
varian function, synchronization of donor-recipient cycle presents a specia
l problem, as there is strong evidence that a temporal window of maximal en
dometrial receptivity exists, Cryopreservation of donated embryos may be us
ed to overcome the problem, but this approach has the important drawback of
embryonic loss occurring after freezing and thawing. The method of choice
is the administration of gonadotrophin-releasing hormone agonists (GnRHa) t
o render the patients functionally agonadal in order to circumvent cycle as
ynchrony between the donor and recipient.